Serum angiotensin converting enzyme (ACE) in hymenoptera venom allergic patients with specific immunotherapy (SIT)

A. Safianowska, A. Dabrowski, M. Paplinska, R. Chazan (Warsaw, Poland)

Source: Annual Congress 2007 - New mechanisms in the pathogenesis of asthma and allergy
Session: New mechanisms in the pathogenesis of asthma and allergy
Session type: Electronic Poster Discussion
Number: 1681
Disease area: Airway diseases

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
A. Safianowska, A. Dabrowski, M. Paplinska, R. Chazan (Warsaw, Poland). Serum angiotensin converting enzyme (ACE) in hymenoptera venom allergic patients with specific immunotherapy (SIT). Eur Respir J 2007; 30: Suppl. 51, 1681

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Bronchial reactivity for histamine and serum angiotensin converting enzyme (sACE) activity in sarcoidosis patients
Source: Eur Respir J 2004; 24: Suppl. 48, 669s
Year: 2004

Clinical significance of angiotensin converting enzyme (ACE) activity in sarcoidosis
Source: Eur Respir J 2001; 18: Suppl. 33, 384s
Year: 2001

Serum angiotensin converting enzyme (ACE) as additional clinical markers of activity of pulmonary and extra-pulmonary locations of sarcoidosis
Source: Annual Congress 2011 - Different profiles of sarcoidosis and other granulomatous disorders
Year: 2011

Activity and phenotypes of angiotensin-converting enzyme (ACE) in sarcoidosis with various organ involvement
Source: Virtual Congress 2020 – Genetics and biomarkers for diagnosis and prognosis of granulomatous lung diseases
Year: 2020


Impact of statins, angiotensin-converting enzyme inhibitors (ACEI), and angiotensin receptor blockers (ARBS) on reducing COPD morbidity
Source: Annual Congress 2009 - Treatment of airways disease
Year: 2009


Circulating d-Dimer lysozyme and angiotensin-converting enzyme in active sarcoidosis
Source: Eur Respir J 2001; 18: Suppl. 33, 196s
Year: 2001

Impact of statins, angiotensin-converting enzyme inhibitors(ACEI), and angiotensin receptor blockers (ARBs) on reducing COPD morbidity
Source: Annual Congress 2010 - COPD: management
Year: 2010


Angiotensin II receptor blockers, ACE inhibitors, lung function and percent emphysema; the MESA lung study
Source: Annual Congress 2012 - Asthma and COPD: quality of life and comorbidities
Year: 2012

Correlation between angiotensin-converting enzyme (ACE) gene polymorphism and exercise performance in COPD patients
Source: Annual Congress 2010 - Exercise in COPD
Year: 2010

Anti-asthmatic effects of losartan, a blocker of angiotensin II type 1 receptor, in a rat model of allergic asthma
Source: Annual Congress 2009 - Preclinical models in drug development
Year: 2009

Angiotensin-converting enzyme genotype and C-reactive protein in patients with COPD
Source: Eur Respir J 2007; 29: 816-817
Year: 2007


Angiotensin-converting enzyme 2 expression is not induced by the renin–angiotensin system in the lung
Source: ERJ Open Res, 6 (4) 00402-2020; 10.1183/23120541.00402-2020
Year: 2020



Effectiveness and safety of the antihypertensive treatment with ACE inhibitors (ACEi) and their combination with calcium antagonists (CA) of the patients with bronchial asthma (BA) and arterial hypertension (AH)
Source: Annual Congress 2008 - Asthma control or asthma severity
Year: 2008

The in vivo activity of AWD 12-353, a potent phosphodiesterase 4 (PDE) inhibitor for the treatment of allergic asthma and COPD
Source: Eur Respir J 2003; 22: Suppl. 45, 107s
Year: 2003

Angiotensin-converting enzyme inhibitor use and pneumonia risk in a general population
Source: Eur Respir J 2006; 27: 1217-1222
Year: 2006



Identification of wheatsubtilisin/chymotrypsin inhibitor (WSCI) as an important allergen for Baker‘s asthma
Source: Eur Respir J 2006; 28: Suppl. 50, 677s
Year: 2006

Effect of angiotensin converting enzyme (ACE) gene polymorphism on diaphragmatic endurance in neonates
Source: Annual Congress 2008 - Neonatal intensive care: ventilation and beyond
Year: 2008

Value of serum angiotensin converting enzyme (SACE) level in the assessment of lung parenchyma impairment in newly diagnosed sarcoidosis
Source: Eur Respir J 2003; 22: Suppl. 45, 45s
Year: 2003

Etiology specific reductions in pulmonary endothelial angiotensin converting enzyme activity in patients with PAH
Source: Eur Respir J 2006; 28: Suppl. 50, 658s
Year: 2006

Cough among hypertensive patients treated with angiotensin convertase inhibitors. Reduction of its frequency by substitution of angiotensin convertase inhibitor with angiotensin receptor blocker. Results of non-interventional, observational postmarketing study
Source: Annual Congress 2011 - The new clinical spectrum of lung diseases: from bronchi to pleura
Year: 2011